Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New Na+/Ca2+ exchanger inhibitors and their use as antiarrhythmic agents

Sep. 8, 2004

CV scientists describe novel fatty acid oxidation inhibitors

Sep. 7, 2004

New evidence on the association between Lp-PLA2 and the risk of CHD and stroke

Sep. 7, 2004

Dronedarone found to reduce the risk of recurrence of atrial fibrillation or flutter

Sep. 6, 2004

Long-term improvements found with sitaxsentan in PAH patients

Sep. 6, 2004

Statin therapy reduces cardiovascular risk in type 2 diabetes

Sep. 6, 2004

New NO-donating rapamycin derivatives described by NitroMed

Sep. 3, 2004

JTE-607 induces cardioprotective effects in a rat model of ischemia and reperfusion

Sep. 3, 2004

Phase I/II trial for EW-A-401

Sep. 2, 2004

Novel MIF ligands and their use covered by Takeda patent

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...